David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #249

32m 153K views 27 Apr 2026

Is it worth your time?

You get a detailed account of upcoming human age reversal trials, the economics of gene therapy, and the specific daily protocols used to extend health span.

This conversation examines the transition of epigenetic reprogramming from animal models to human clinical trials. The discussion covers the technical and financial hurdles of making longevity therapeutics accessible to millions of people.

Human epigenetic reprogramming trials. Sinclair explains that his lab's epigenetic reprogramming technology is entering human clinical trials. He states that a subset of Yamanaka genes known as OSK can reverse aging in tissues without causing cancer or losing cell identity. This gene therapy has already cured blindness in mice and monkeys.

Cost and accessibility of therapeutics. Sinclair notes that traditional adeno-associated virus gene therapies cost between half a million and 2 million dollars per treatment. To reach millions of patients, his lab uses artificial intelligence to screen billions of molecules for cheaper alternatives. He expects that a three-molecule pill could eventually become as inexpensive as metformin.

Private funding models for science. Sinclair argues that traditional grant reviews prioritize predictable science and force researchers to spend months writing proposals. To bypass this bottleneck, he established private funding initiatives that brought in approximately six million dollars in annual support. This direct financial backing allows his team to start new projects within weeks.

Personal longevity protocols. Sinclair details the specific daily regimen he and his father have followed for over 15 years. He takes resveratrol mixed with an oily substance, nicotinamide mononucleotide, and a gram of metformin daily. He claims that eliminating alcohol and reducing stress significantly lowered his inflammation biomarkers.

The Dawn of Epigenetic Reprogramming

Coffee is actually good for you. Studies show that caffeine and the other molecules in the bean are beneficial; I drink about three cups. While coffee comes in and out of fashion, it is currently viewed positively for longevity. Serena and I drink tea all day until we can't take any more caffeine.

I am excited to update everyone on our approach toward longevity singularity: the moment in time when we know we are extending the healthy human lifespan. You are days away from the first human epigenetic reprogramming trial. We have a drug candidate from my lab, first published in 2020 on the cover of Nature magazine with the title "Turning Back Time." I want to give big credit to my student, Onecheng Lu, who worked for many years to find certain genes and combinations that could safely reverse aging without causing cancer or losing the identity of the cell.

Exploring the Potential of Longevity Therapeutics

It took a long time and was tough at the time; he was ready to quit. Eventually, he found a subset of three Yamanaka genes, which we call OSK for short. While these genes are used to make stem cells, we don't want to use the technology for that; if I turned you all into a giant lump of stem cells, that would not be good, and mice die within two days if you use all of Yamanaka's genes.

Having succeeded in curing blindness in mice and monkeys, we are shortly putting them into the eye of a patient. I know a number of you are investors along with me in Life Biosciences, and I am super excited about reversing blindness. I thought the liver would be a good way to go, and that is probably the next place we go in the human body.

We see benefits in every tissue we enter as a field. Currently in mice, this includes brain age reversal with improvement in memory in old age and Alzheimer's models, as well as motor neurons for ALS, which is currently an incurable disease we think we can help. The list goes on: the immune system, muscle, kidney, liver, and skin. Regarding joints, a new paper from a different group came out last week that I tweeted about. Since we all experience back or joint pain, it is great that this technology seems to regrow the joint, cartilage, and even the bone.

Innovations in Gene Therapy and Accessibility

A true longevity therapeutic wouldn't just work in one cell type, like hepatocytes, but throughout the entire body. We are going after one tissue at a time because this technology is untested in humans and the FDA just recently allowed Life Biosciences into the clinic. Had we proposed injecting the whole body, the FDA would have been much more cautious. As we learn more about safety, I see no reason why we couldn't eventually go intravenously.

Right now, we use viral-like particles to target the eye and liver. While great for targeting, a whole-body approach will require lipid nanoparticles or a chemical small molecule. Current treatments entering trials use adeno-associated viruses (AAV) to deliver OSK, which is an expensive mechanism—traditionally costing between half a million and 2 million dollars per treatment. Since we want to treat millions of patients, including those with glaucoma, we need alternatives.

My graduate students developed an extraordinary alternative, which is also our entry into the Healthspan X Prize. The technology currently entering human trials, for which patients are being recruited now, is actually 2017 technology from the Sinclair lab.

The Future of Longevity: Cost and Accessibility

I point out to my students that what we published is literally going into humans. It is rare for a PhD student to make a drug that goes into humans, but he did it.

Since 2017, my lab has worked on bringing the price down. The cheapest option is a small molecule, which could potentially be made for a few cents a pill. Even with ER100, the viral candidate drug going into humans, you only need six weeks of dosing. These chemicals could be very cheap.

We have used artificial intelligence to screen billions of molecules in silico. We are now in the lab using AI, visualization, and machine learning to see if skin cells from 92-year-old humans can be reversed back to a 20-year-old. We know the OSK gene therapy works, and we are looking for molecules that do the same. We already have a proof of concept—a cocktail of molecules, some of which we published on a couple of years ago—that we hope to put into human clinical trials within the next couple of months as part of our Xprize competition.

While adeno-associated virus gene therapies cost hundreds of thousands to low millions, a three-molecule pill would be different. The FDA makes it difficult to make cocktails, and these three-factor molecules currently cost hundreds of thousands of dollars to make at a kilogram scale. One day, I hope it will be as cheap as metformin.

The Science of Aging: Limits and Possibilities

One of the precepts of the Healthspan Xprize that Dr. Jamie Justice runs is encouraging the development of therapeutics accessible to 8 billion people. When technology first emerges and doesn't work well, the wealthy experiment with it; by the time it works really well, it's available to everyone.

This feels like another Wright brothers moment. People said it wouldn't work; the New York Times claimed a few weeks before they took off that it would be a million years before humans fly. Then they did it. Flying was initially for the wealthy in the early 20th century and even up until the '60s and '70s.

I can see a future where these pills are available within our lifetime. I may be most advanced in the work we're doing, but there are lots of people and money behind us. Twenty years ago, I didn't know if this would happen in our lifetimes, but now the wave is such that it will. 2026 may be the year we learn that age reversal is possible in humans.

Funding Science: A New Approach to Research

I'm speed running Star Trek, as I like to say. Peter does a lot of good for the world and is unique in doing that. Among many things he's done for the field of longevity is the X Prize with Jamie Justice. It's a wonderful cause; I would not be putting our chemical cocktail, which we've now tested extensively in animals, into people if it weren't for the X Prize. We're trying to accelerate the future.

People need to understand that the conversation around longevity and the pioneering work you did early on had a lot of pushback. There was a negative stigma against doing work in this field, yet you saw the potential and persisted. You're a dear friend, and I've heard the trials and tribulations you've persisted through with Serena's support.

Is there an upper limit to how long humans can live? Are we aiming for 120 or 130? People say we might extend health span by a few decades, but we're going to time out. What do you think?

As I wrote in the book Lifespan, there is no law that says we have to age. Anyone who says there is a limit doesn't know what they're talking about. We can live hundreds of years. Some people live well beyond 100, up to a maximum of 122.

Personal Longevity Protocols and Lifestyle Choices

I see no biological or physical reason why there is a limit. There is a reboot system in cells that can literally reset a cell so it is young, rather than just behaving young, which is what we did for the first 20 years in the field. Because there is a backup copy, we know you can reboot cells over and over. We don't know how many times because we did it multiple times in the eye of mice until they died of old age, but they had really good eyesight. We are now working to do this multiple times in a whole animal.

Just as the Wright brothers' flight signaled the future of the Concorde jet and going to the moon, the same applies to longevity. Once you can fly, everything changes, and I think we're about to learn whether we can fly. Between the work from Layla and other speakers, the field of AI creates an accelerating future where added time brings breakthroughs that make the exponent greater than one.

At my Moonshots podcast studio in Santa Monica, David was glum because his funding was cut due to a battle between the White House and Harvard, and he had to let his graduate students go. When you see a problem, your answer is that you're going to solve it. I said, "Let's create Friends of Sinclair Lab. I'll contribute the first 50K, but let's ask the Moonshots audience to participate." Max Song instantly spun up a website and QR codes. Including fellowships my scientists brought, we brought in on the order of six million dollars of private annual support over the next few months.

There is a perversion in how we fund science. People reviewing grants don't want radical science; they want predictable science where they know the answer. You write a grant that takes a year or two to get funded with only a 10% chance of success. In the Sinclair lab, some have given 50K and some up to a million; this money goes directly to David and his grad students where the highest signal is. It unleashes you to do work on the cutting edge. Thanks to the Friends, we are in better shape now than we were a year ago.

We used to be limited by grants, and I spent half my time writing them. We have PhDs and professors—some of the smartest minds in the country—typing grants all day instead of doing the work.

During a bi-monthly Zoom call with friends, my student presented her data and said, "Sorry, I couldn't present last time. My kidneys are failing. I had dialysis today. I need a new kidney." Brett Blundy, a member of our community and a benefactor for the Health Span Prize and X Prize, asked, "How fast can we cure this?" I said, "Let's do it," and he agreed to fund the project. Now we can start within weeks of an idea instead of years, if ever. This is how science should be done, and now that this model has proven to work brilliantly, I want to teach the best minds across the world that this is a much better way.

Regarding my complexion, physique, and longevity escape velocity, what I wrote in Lifespan still holds true; check page 304. My father, now 86 and in perfect health, and I have taken three main staples for over 15 years, and we have good data on this to submit to Nature. First is resveratrol, an activator of SIRT1, a longevity enzyme we've worked on for many years linked to the information theory of aging. It must be mixed with olive oil, yogurt, or something oily or proteinaceous to dissolve, otherwise it mostly passes straight through you. Second is NMN, or nicotinamide mononucleotide. Third is metformin, a type 2 diabetes drug requiring a prescription; we take a gram a day. There is also a natural version called berberine, which has clinical data showing benefits including lowering blood glucose.

At Fountain Life, we found that the number one thing correlating with heart disease is not your HDL or LDL, but Lp(a).

The number one thing that correlates to heart disease is your hemoglobin A1C and glucose levels. In the last couple of years, we've added nattokinase, a natural enzyme from natto—the Japanese breakfast that smells like vomit. It is the only thing clearly shown in large trials of over a thousand people to reverse plaque in the body. I take the pills, and you need a consistent dose of 10,000 units for a year. I'm going to have my carotid ultrasound again to see if my IMT has changed.

As a trained physician, make sure you don't die from something stupid like a stroke or heart attack if you don't need to. You can get a CT scan, but that involves radiation, which my lab knows accelerates aging. I prefer to avoid radiation, and ultrasound is a safe 20-minute scan of your neck. For those of you on the longevity trip, we give you a carotid scan every year.

Regarding food, I've gone vegan. I'm a sucker for Japanese sushi, but Serena inspired me. At a gathering for friends of the Sinclair Lab, I admitted that what turned me on with Serena was her talk about navitoclax and dasatinib as a senolytic. I stopped drinking alcohol a few months after I met her, much to the chagrin of my spouse, who is a sommelier. Data now shows that even one glass of alcohol a day correlates with a smaller brain. We must be driven by science, not by what we want. While celebrating a few times a year doesn't hurt, I used to drink daily. I used to claim eating cheese and red wine every night was the Mediterranean diet, but within a month of changing, my inflammation biomarkers went way down.

Serena changed my life. I'm very hard on myself; if I'm not number one, I'm not happy. Until I met Serena, I lived on edge, ruminating and stressing that I wasn't good enough. She taught me to breathe, chill, and meditate. I'm still working on it, but I've learned not to worry so much. I'm sleeping, looking, and feeling better because constant tension accelerates aging.

To live longer, monitor your blood pressure, cholesterol, and blood sugar. Get a pet and a partner; ensure you are socially surrounded by people who love you, because loneliness will kill you.

Mentioned

People

Onecheng Lu Jamie Justice Wright brothers Max Song Brett Blundy

Companies

Life Biosciences Sinclair lab Harvard Fountain Life